Concord Biotech Ltd Q3 FY2024-2025 Results: Summary
Revenue | ₹260.78Cr |
Net Profits | ₹75.92Cr |
Net Profit Margins | 29.11% |
Concord Biotech Ltd’s revenue jumped 3.48% since last year same period to ₹260.78Cr in the Q3 2024-2025. On a quarterly growth basis, Concord Biotech Ltd has generated -18.56% fall in its revenue since last 3-months.
Concord Biotech Ltd’s net profit fell -2.13% since last year same period to ₹75.92Cr in the Q3 2024-2025. On a quarterly growth basis, Concord Biotech Ltd has generated -20.7% fall in its net profits since last 3-months.
Concord Biotech Ltd’s net profit margin fell -5.42% since last year same period to 29.11% in the Q3 2024-2025. On a quarterly growth basis, Concord Biotech Ltd has generated -2.63% fall in its net profit margins since last 3-months.
FAQs
What was the revenue for Concord Biotech Ltd in Q3 results 2024?
The revenue for Concord Biotech Ltd in the Q3 results 2024 was ₹260.78Cr.
What was the net profit for Concord Biotech Ltd in Q3 results 2024?
The net profit for Concord Biotech Ltd in the Q3 results 2024 was ₹75.92Cr.
What was the net profit margin for Concord Biotech Ltd in Q3 results 2024?
The net profit margin for Concord Biotech Ltd in the Q3 results 2024 was 29.11%.
What was the revenue for Concord Biotech Ltd in Q3 results 2023?
The revenue for Concord Biotech Ltd in the Q3 results 2023 was ₹252Cr.
What was the net profit for Concord Biotech Ltd in Q3 results 2023?
The net profit for Concord Biotech Ltd in the Q3 results 2023 was ₹77.57Cr.
What was the net profit margin for Concord Biotech Ltd in Q3 results 2023?
The net profit margin for Concord Biotech Ltd in the Q3 results 2023 was 30.78%.
